Implementations by Phenotype

Title Phenotype Institution Algorithm Type Total Casessort ascending Total Controls PPV Sensitivity
Northwestern University Validation Colorectal Cancer (CRC) Northwestern University Case, Control 50 50 86%, 98% 92%
Marshfield Venous Thromboembolism implementation Venous Thromboembolism (VTE) Marshfield Clinic Research Foundation Case, Control 50 49 98%, 100%
Marshfield diverticulosis/diverticulitis implementation Diverticulosis and Diverticulitis Marshfield Clinic Research Foundation Case, Control 50 50 100%, 100%
Autism Validation Autism CHOP Case Only 50 85% 74%
AMI/1st AMI Vanderbilt Implementation Statins and MACE Vanderbilt University Case Only 50 96%
Statins and MACE Marshfield Implementation Statins and MACE Marshfield Clinic Research Foundation Case Only 50 100% 100%
Nortwestern University e3 Implementation CAAD (Carotid Artery Atherosclerosis Disease) Northwestern University Case, Control 48 133
Harvard CDiff Clostridium Difficile Colitis Harvard Medical School Case Only 47 1,643
Hypothyroidism Implementation - Columbia Hypothyroidism Columbia University Case, Control 45 129
Northwestern Univ. CAAD CAAD (Carotid Artery Atherosclerosis Disease) Northwestern University Case, Control 44 461
Statin and MACE Implementation - Columbia Statins and MACE Columbia University Case, Control 41 570
Columbia - Migraine Migraine Columbia University Medical Center Case, Control 37 2,294
Migraine--Columbia Migraine Columbia University Case, Control 37 2,294
NU appendicitis cases Appendicitis Northwestern University Case Only 30 100%
Emerge III Implementation Appendicitis Geisinger Case, Control 30 13,032
Geisinger Zoster Implementation Herpes Zoster Geisinger Case, Control 27 27 89%, 96% 100%
Marshfield Hearing loss validation Hearing Loss Marshfield Clinic Research Foundation Case, Control 25 25 100%, 100%
Group Health/University of Washington CRC Validation Colorectal Cancer (CRC) GH/UW Case, Control 25 25 92%, 100% 100%, 100%
Marshfield AAA implementation Abdominal Aortic Aneurysm ( AAA ) Marshfield Clinic Research Foundation Case, Control 25 22 100%, 100%
Implementation For Phase 3 eMERGE Electronic Health Record-based Phenotyping Algorithm for Familial Hypercholesterolemia Geisinger Case, Control 25 25 100%, 96%
Marshfield ACE-I cough implentation ACE Inhibitor (ACE-I) induced cough Marshfield Clinic Research Foundation Case, Control 25 25 100%, 96%
Geisinger Impl Colorectal Cancer (CRC) Geisinger Case, Control 25 25 100%, 100%
Geisinger caMRSA Implementation caMRSA Geisinger Case, Control 25 25 96%, 100% 96%
Group Health and UW Zoster Implementation Herpes Zoster Group Health and UW Case, Control 25 25 100%, 96% 100%
Intellectual disability Adult population Intellectual Disability Vanderbilt Case, Control 25 6,231

Pages